Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant

View ORCID ProfileRenato Mendes Coutinho, Flavia Maria Darcie Marquitti, Leonardo Souto Ferreira, Marcelo Eduardo Borges, Rafael Lopes Paixão da Silva, Otavio Canton, Tatiana P. Portella, Silas Poloni Lyra, Caroline Franco, Antonio Augusto Moura da Silva, Roberto A. Kraenkel, Maria Amélia de Sousa Mascena Veras, Paulo Inácio Prado
doi: https://doi.org/10.1101/2021.03.03.21252706
Renato Mendes Coutinho
1Universidade Federal do ABC, Santo André, SP, Brazil
7Observatório COVID-19 BR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Renato Mendes Coutinho
  • For correspondence: renato.coutinho@gmail.com
Flavia Maria Darcie Marquitti
2Universidade Estadual de Campinas, Campinas, SP, Brazil
7Observatório COVID-19 BR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonardo Souto Ferreira
3Universidade Estadual Paulista, São Paulo, SP, Brazil
7Observatório COVID-19 BR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcelo Eduardo Borges
7Observatório COVID-19 BR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rafael Lopes Paixão da Silva
3Universidade Estadual Paulista, São Paulo, SP, Brazil
7Observatório COVID-19 BR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otavio Canton
3Universidade Estadual Paulista, São Paulo, SP, Brazil
6Universidade Federal do Maranhão, São Luís, MA, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatiana P. Portella
4Universidade de São Paulo, São Paulo, SP, Brazil
7Observatório COVID-19 BR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silas Poloni Lyra
3Universidade Estadual Paulista, São Paulo, SP, Brazil
7Observatório COVID-19 BR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Franco
3Universidade Estadual Paulista, São Paulo, SP, Brazil
7Observatório COVID-19 BR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Augusto Moura da Silva
6Universidade Federal do Maranhão, São Luís, MA, Brazil
7Observatório COVID-19 BR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberto A. Kraenkel
3Universidade Estadual Paulista, São Paulo, SP, Brazil
7Observatório COVID-19 BR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Amélia de Sousa Mascena Veras
5Faculdade de Ciências Médicas da Santa Casa de São Paulo – São Paulo, SP, Brazil
7Observatório COVID-19 BR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paulo Inácio Prado
4Universidade de São Paulo, São Paulo, SP, Brazil
7Observatório COVID-19 BR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The variant of concern (VOC) P.1 emerged in the Amazonas state (Brazil) and was sequenced for the first time on 6-Jan-2021 by the Japanese National Institute of Infectious Diseases. It contains a constellation of mutations, ten of them in the spike protein. Consequences of these mutations at the populational level have been little studied so far. From December-2020 to February-2021, Manaus was devastated by four times more cases compared to the previous peak (April-2020). Here, data from the national health surveillance of hospitalized individuals and frequency of the P.1 variant were analysed using a model-based approach to estimate P.1 parameters of transmissibility and reinfection by maximum likelihood. Sensitivity analysis was performed changing pathogenicity and the period analysed (including/excluding the health system collapse period). The new variant transmissibility was found to be about 2.5 times higher (Confidence Interval (95%CI): 2.3–2.8) compared to the previous variant in Manaus. A low probability of reinfection by the new variant (6.4%, 95%CI: 5.7–7.1%).) was estimated, even under initial high prevalence (68%, 95%CI: 63– 74%), by the time P.1 emerged. Consequences of a higher transmissibility were already observed with VOC B.1.1.7 in the UK and Europe. Urgent measures must be taken to control the spread of P.1.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

Ethics approval was not necessary because this study analysed only publicly available data, not including identifiable information.

Funding Statement

This work was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil (Finance Code 001 to FMDM, LSF and TPP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (grant number: 315854/2020-0 to MEB, 141698/2018-7 to RLPS, 313055/2020-3 to PIP, 312559/2020-8 to MASMV, 311832/2017-2 to RAK, 305703/2019-6 to AAMS) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (grant number: 2019/26310-2 and 2017/26770-8 to CF, 2018/26512-1 to OC, 2018/24037-4 to SPL and contract number: 2016/01343-7 to RAK).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics approval was not necessary because this study analysed only publicly available data, not including identifiable information.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data used are publicly available. The data sources are described in the manuscript and in supplementary file.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted March 09, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant
Renato Mendes Coutinho, Flavia Maria Darcie Marquitti, Leonardo Souto Ferreira, Marcelo Eduardo Borges, Rafael Lopes Paixão da Silva, Otavio Canton, Tatiana P. Portella, Silas Poloni Lyra, Caroline Franco, Antonio Augusto Moura da Silva, Roberto A. Kraenkel, Maria Amélia de Sousa Mascena Veras, Paulo Inácio Prado
medRxiv 2021.03.03.21252706; doi: https://doi.org/10.1101/2021.03.03.21252706
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant
Renato Mendes Coutinho, Flavia Maria Darcie Marquitti, Leonardo Souto Ferreira, Marcelo Eduardo Borges, Rafael Lopes Paixão da Silva, Otavio Canton, Tatiana P. Portella, Silas Poloni Lyra, Caroline Franco, Antonio Augusto Moura da Silva, Roberto A. Kraenkel, Maria Amélia de Sousa Mascena Veras, Paulo Inácio Prado
medRxiv 2021.03.03.21252706; doi: https://doi.org/10.1101/2021.03.03.21252706

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8787)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1863)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (492)
  • Hematology (207)
  • HIV/AIDS (394)
  • Infectious Diseases (except HIV/AIDS) (10563)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1755)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (965)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (176)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (265)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1844)
  • Public and Global Health (3985)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)